Health ❯ Healthcare ❯ Biotechnology

Drug Development

Clinical Trials Inflammatory Diseases Gene Therapy Obesity Treatments Rare Diseases Oncology Clinical Research Cancer Research Obesity Treatment Molecular Glue Degraders Petosemtamab Gilead Sciences Mental Health Treatments Corcept Therapeutics Incorporated Allergy Treatments Hypertrophic Cardiomyopathy Regulatory Challenges Therapeutics mRNA Vaccines FDA Approval Startup Support Cell Therapy Neuromuscular Disorders

Novo Nordisk Strikes Up to $2.1 Billion Deal With Vivtex for Next-Gen Oral Obesity and Diabetes Drugs

The partnership taps Vivtex’s robotics-driven GI screening plus AI formulation platform to convert injectable biologics into pills.

Stories older than 24h

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

Jan. 16 Deadline Nears in Skye Bioscience Investor Class Actions

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

Skye Bioscience Investors Pressed to Seek Lead Role After Class Action Filing

Sofinnova Closes €650 Million Capital XI to Back Early-Stage Biotech and Medtech

MoonLake Investors Courted for Lead Role in SDNY Securities Case After SLK Trial Collapse

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in SDNY Securities Case

MoonLake Faces Securities Class Action After SLK Trial Miss as Firms Seek Lead Plaintiff

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Kriya Nets $320 Million Series D as Odyssey Raises $213 Million and Amgen Retools Research Leadership

Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund

FDA Flags Possible License Revocation for Sarepta’s Elevidys

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial